Modified keratin sponge: Binding of bone morphogenetic protein-2 and osteoblast differentiation

Journal of Bioscience and Bioengineering

Volumn 102, Issue 5, 2006, Pages 425-429

  Tachibana, Akira ^a   Nishikawa, Yuji ^a   Nishino, Masaaki ^a   Kaneko, Sumika ^a   Tanabe, Toshizumi ^a   Yamauchi, Kiyoshi ^a  

^a Osaka City University   (Japan)

Author keywords

keratin sponge; osteoblast differentiation; osteoblast scaffolds; retention of bone morphogenetic protein 2 (BMP 2) in scaffolds; scaffold bone morphogenetic protein 2 (BMP 2) interaction

Indexed keywords

ALKYLATION; BONE; CELLS; DRUG DOSAGE;

AMINO SPONGES; KERATIN SPONGE; OSTEOBLAST DIFFERENTIATION; OSTEOBLAST SCAFFOLDS; SCAFFOLD-BONE MORPHOGENETIC PROTEIN-2 (BMP-2) INTERACTION;

PROTEINS;

2 BROMOETHYLAMINE; BONE MORPHOGENETIC PROTEIN 2; CARBOXYL GROUP; CYTOKINE; IODOACETIC ACID; KERATIN; LYSOZYME;

ALKYLATION; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHEMICAL MODIFICATION; IONIC STRENGTH; OSSIFICATION; OSTEOBLAST; PROTEIN BINDING;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; KERATINS; MICE; MURAMIDASE; OSTEOBLASTS; OSTEOGENESIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845624475     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.102.425     Document Type: Article

References (15)

1. Wozney J.M. The bone morphogenetic protein family: multifuctional cellular regulators in the embryo and adult. Eur. J. Oral Sci. 106 (1998) 160-166
2. Li R.H., and Wozney J.M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19 (2001) 255-265
3. Yamamoto M., Takahashi Y., and Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopid bone formation of bone morphogenetic protein. Biomaterials 24 (2003) 4375-4383
4. Wildemann B., Kandziora F., Krummrey G., Palasdies N., Haas N.P., Raschke M., and Schrnidmaier G. Local and controlled release of growth factors (combination of IGF-1 and TGF-beta1, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle. J. Control. Release 95 (2004) 249-256
5. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Müller R., and Hubbell J.A. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 21 (2003) 513-518
6. Friess W., Uludag H., Foskett S., Biron R., and Sargeant C. Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int. J. Pharm. 187 (1999) 91-99
7. Geiger M., Li R.H., and Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 55 (2003) 1613-1629
8. Doillon C.J., Drouin R., Cote M.F., Dallaire N., Pageau J.F., and Laroche G. Chemical inactivatores as sterilization agents for bovine collagen materials. J. Biomed. Mater. Res. 37 (1997) 212-221
9. Tanabe T., Tachibana A., and Yamauchi K. Keratins: prospective proteiunous biomaterial. Recent Res. Dev. Protein Eng. 1 (2001) 247-259
10. Tachibana A., Furuta Y., Takeshima H., Tanabe T., and Yamauchi K. Fabrication of wool keratin sponge scaffolds for long-term cell cultivation. J. Biotechnol. 93 (2002) 165-170
11. Tachibana A., Kaneko S., Tanabe T., and Yamauchi K. Rapid fabrication of keratin-hydroxyapatite hybrid sponges toward osteoblast cultivation and differentiation. Biomaterials 26 (2005) 297-302
12. Kurimoto A., Tanabe T., Tachibana A., and Yamauchi K. Thiolated dermal bovine collagen as a novel support for bioactive substances - conjugation with lysozyme. J. Biotechnol. 86 (2001) 1-8
13. Kurimoto A., Tanabe T., Tachibana A., and Yamauchi K. Keratin sponge: immobilization of lysozyme. J. Biosci. Bioeng. 96 (2003) 307-309
14. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83 (1977) 346-356
15. Suzawa M., Takeuchi Y., Fukumoto S., Kato S., Ueno N., Miyazono K., Matsumoto T., and Fujita T. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 140 (1999) 2125-2133